Christopher Karlovich, Ph.D.

Associate Director, Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research

Chris Karlovich is Associate Director of the Molecular Characterization (MoCha) Laboratory at the Frederick National Laboratory for Cancer Research (FNLCR). The mission of MoCha is to develop genomic assays in support of research and clinical studies sponsored by the National Cancer Institute. In this capacity, MoCha has played a key role in several NCI precision medicine initiatives including NCI-MATCH, NCI-COG Pediatric MATCH and MPACT. Technologies either implemented or under validation at MoCha include whole exome sequencing, RNA-Seq, single cell genomics, and TSO500 ctDNA for liquid biopsies. Prior to coming to FNLCR Dr. Karlovich was at Clovis Oncology, where he provided scientific and operational oversight over molecular diagnostics and companion diagnostic development for rociletinib, a mutant-selective inhibitor of EGFR, and for rucaparib, a PARP inhibitor. Dr. Karlovich also spent nine years at Roche Molecular Diagnostics in biomarker discovery and in vitro diagnostic (IVD) test development.